Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow's leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Give to Mayo ClinicYou are an essential partner in our work to find answers for our patients. Donate now.
Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER-2+ Breast Cancer Patients, Study Finds
Posted: Mon, Dec 8 11:39am by Paul Scotti · Discussion
Perez: Immune Function Marker - Edited PKG (4:19)
Posted: Thu, Dec 4 2:13am by Jason Pratt · Media
Perez: Immune Function Marker - Implications for Practice (:53)
Perez: Immune Function Marker - Study Results (1:24)
Posted: Thu, Dec 4 2:12am by Jason Pratt · Media
Perez: Immune Function Marker - Current Standard (:27)
Perez: Immune Function Marker - Evaluation (:20)
Perez: Immune Function Marker - Background (1:00)
Em mais de oito anos de tratamento do câncer de mama HER2-positivo em estágio inicial, o trastuzumabe continua a apresentar benefícios para sobrevida das pacientes
Posted: Mon, Oct 27 4:36pm by Kevin Punsky · Discussion
version 2.8.7Page loaded in 0.171 seconds